###### Strengths and limitations of this study

-   There is no study about the relationship between neuron-specific enolase (NSE) and metabolic syndrome (MS); this study based on a large sample of population revealed that NSE and MS may probably have a causal relationship.

-   The health check-up population varies from the general population, so that the representativeness of this conclusion is limited.

-   This cross-sectional study was carried out in one hospital that might not consider the population in other settings.

-   Brain MRI was not performed to evaluate the degree of brain impairment; thus, the interpretation of the inherent association mechanism between NSE and MS is limited.

Introduction {#s1}
============

Metabolic syndrome (MS) and its components are important factors in cerebrovascular diseases. The components of MS, such as overweight or obesity, hypertension, hyperlipidaemia and hyperglycaemia, are independently or jointly linked to the aetiology of atherosclerosis and stroke.[@R1] It has been reported that the risks of atherosclerosis in MS population over 5--10 years were two times higher than those in non-MS population.[@R8] People with MS have a higher prevalence of cerebral events, especially of non-fatal ischaemic stroke.[@R9] This relationship has been confirmed by other studies.[@R10]

Neuron-specific enolase (NSE) is one of the isozymes of the enolase family. Two of the three subunits which constitute the enolase family form two types of dimers (αγ and γγ), which specifically exist in neurons.[@R13] NSE is a tumour marker, especially in detecting small cell lung cancer.[@R14] In 1997, Missler *et al* found a trend towards elevated levels of NSE in patients with stroke[@R16]; subsequently, number of studies revealed that serum NSE was elevated in patients with brain injury.[@R17] It has been shown that NSE is more efficient when used in conjunction with other biomarkers in assessing the risk of cardiovascular disease and transient ischaemic attack.[@R21] Thus, NSE is also considered as a sensitive marker for evaluating the severity of craniocerebral injury and prognosis of relevant diseases.[@R23]

However, there are no reports on the association between NSE and MS, although. Studies have demonstrated the relationship of MS with brain dysfunction, and the association between blood pressure (BP), blood glucose and NSE.[@R24] If a predictive relationship exists between NSE and MS or its components, it will be of immense value in early diagnosis of the impairment of brain function by MS.

This current investigation is a cross-sectional study on a large health check-up population with the aim of exploring the relationship between NSE and MS and its components.

Methods {#s2}
=======

Patients {#s2a}
--------

A health check-up population from the Physical Examination Center of the First Affiliated Hospital of Wannan Medical College, in Wuhu, China, was enrolled in this study from 2014 to 2016. Inclusion criteria: (1) age within the range 18--89 years; (2) evidence of having undergone tumour marker tests and (3) the absence of history of brain disease intervention. The exclusion criteria included: (1) the absence of available data on triglyceride (TG), fasting blood glucose (FBG), uric acid, high-density lipoprotein, blood urea nitrogen (BUN), glutamic--pyruvic transaminase, glutamic oxaloacetate, aminotransferase, NSE; (2) individuals with brain disease intervention, tumour or cancer, severe cardiovascular diseases or severe infections. A total of 40 684 subjects consisting 25 604 (62.93%) men and 15 080 (37.07%) women were enrolled in this cross-sectional study. Their mean age was 50.49±13.52 years. The study was conducted in compliance with Helsinki guidelines of the Helsinki Declaration of World Medical Association. Verbal informed consent was obtained from each participant before the investigation.

Questionnaire survey {#s2b}
--------------------

A questionnaire was designed by clinical and epidemiological experts. It contained demographic and behavioural characteristics, history of diseases and operations, and body examinations. The demographic characteristics included sex, age, occupation, educational backgrounds, and so on. The behavioural characteristics included smoking (scored as 0=never smoking, 1=smoking occasionally and 2=smoking frequently) and drinking (scored as 0=never drinking, 1=drinking occasionally and 2=drinking frequently). The history of diseases and operations included the information of severe infections, cardiovascular diseases, major surgeries and tumour or cancer.

Physical examination {#s2c}
--------------------

The physical examination included height, weight and BP. Subjects were assessed when barefooted by professional staff. They were required to have their eyes straight ahead and upper limbs put on both sides of the body in a natural pose; height data were acquired to the nearest 0.1 cm. The subjects maintained steady body positions during the body weight measurement and wore minimal clothing. Weight data were acquired to the nearest 0.1 kg. The body mass index (BMI) was calculated as: weight (kg)/square of height (m^2^). The BMI data were calculated to the nearest 0.01 kg/m^2^. BP was measured using a mercury sphygmomanometer, after the subjects rested for 5 min. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured.

Biochemical assays {#s2d}
------------------

A total of 5 mL venous blood from each subject was used for the measurement of biochemical indices. The specimens were collected from the participants after 12-hour fast and then centrifuged and stored at −70℃ until assayed. All specimens were assayed within 24 hours. The parameters assayed were TG, FBG, high-density lipoprotein cholesterol (HDL-C), BUN and NSE. The measurement of NSE concentrations was done with commercial ELISA kits (CanAg NSE EIA, Göteborg, Sweden). All biochemical assays were performed by laboratory technicians in the hospital.

Classification of participants/definitions {#s2e}
------------------------------------------

All participants were divided into subgroups according to BMI (≥25 kg/m^2^ group and \<25 kg/m^2^ group) and NSE (≥12.5 ng/mL group and \<12.5 ng/mL group).[@R28] Hypertension was defined as SBP ≥140 mm Hg and/or DBP ≥90 mm Hg or under treatment with antihypertensive drugs. Hyperglycaemia was defined as FBG ≥6.1 mmol/L. Hypertriglyceridaemia was defined as TG ≥1.7 mmol/L. Low high-density lipoprotein referred to HDL-C \<0.9 mmol/L in men, and HDL-C \<1.0 mmol/L in women, while MS was defined according to the Chinese Diabetes Society (CDS) criteria.[@R29]

Statistical analysis {#s2f}
--------------------

Characteristics of the population were illustrated by simple descriptive statistics; the data were expressed as mean ±SD for continuous variables or frequency (%) for categorical variables. The comparison of demographic characteristics and biochemical indices between ≥12.5 ng/mL and \<12.5 ng/mL groups was done using χ^2^ test. Then, multivariable logistic regression model analysis was used to explore the relationship between MS and its components with NSE, and adjusted for possible confounding factors such as sex, age, drinking and BUN, to provide the OR and 95% CI values. Stepwise correlation analysis was used to explore the correlation between the components of MS and NSE. Before and after adjustment for sex, age, drinking and BUN, R package with mgcv and ggplot V.2.0 was used to explore the generalised smoothing splines between NSE and MS components. Linear regression was conducted to estimate the relationship between NSE and MS components with or without adjustment for potential confounders. Participants were divided into four groups by quartiles (\<P~25~, P~25~--P~50~, P~50~--P~75~ and ≥P~75~) of NSE in each segment, and stepwise logistic regression was conducted to test the connection between NSE and MS. All tests were two-sided and statistical significance level was considered as 'α=0.05'. Data management and all analyses were performed using R software program (V.3.0.0).

Patient and public involvement {#s2g}
------------------------------

No patients were involved in developing the questionnaire, the hypothesis and plans or implementation for this study. No patients were involved in the data analysis or the manuscript writing. And we did not plan to disseminate the results of this study to participants or some relevant people.

Results {#s3}
=======

Demographic characteristics and biochemical indices between NSE {#s3a}
---------------------------------------------------------------

The demographic characteristics and biochemical indices of the NSE subgroups are shown in [table 1](#T1){ref-type="table"}. The results show that 26.87% of the population had abnormal NSE level, and the prevalence of MS was 8.85%. In the MS group, NSE concentration was 9.47±6.07 ng/mL, and in non-MS group, the concentration was 9.06±5.83 ng/mL. There were significant differences in BMI, TG, HDL-C and BP between the two NSE groups. In addition, the two NSE groups differed significantly with respect to other baseline characteristics such as sex, drinking habit and BUN.

###### 

Comparison of the demographic characteristics and biochemical indices between NSE subgroups

  Variables                 Total            \<12.50 ng/mL    ≥12.50 ng/mL     χ^2^       P values
  ------------------------- ---------------- ---------------- ---------------- ---------- ----------
  Sex                                                                                     
   Female                   15 080 (37.07)   11 555 (38.83)   3525 (32.27)     147.1634   \<0.0001
   Male                     25 604 (62.93)   18 206 (61.17)   7398 (67.73)                
  Age (years)                                                                             
   \<45                     50.49±13.52      9879 (33.19)     3603 (32.99)     2.4862     0.2885
   45--                     11 671 (39.22)   4372 (40.03)                                 
   59--                     8211 (27.59)     2984 (26.99)                                 
  BMI (kg/m^2^)                                                                           
   \<25                     23.98±3.23       20 223 (67.95)   6868 (62.88)     92.4951    \<0.0001
   ≥25                      9538 (32.05)     4055 (37.12)                                 
  Drinking\*                                                                              
   0                        24 606 (60.48)   18 116 (64.76)   6490 (62.61)     134.8549   \<0.0001
   1                        3660 (9.00)      2879 (10.29)     781 (7.53)                  
   2                        10 076 (24.77)   6981 (24.95)     3095 (29.86)                
  Smoking\*                                                                               
   0                        27 409 (67.37)   20 015 (71.55)   7394 (71.33)     0.4157     0.8123
   1                        8934 (22.00)     6514 (23.29)     2420 (23.35)                
   2                        1998 (4.91)      1446 (5.17)      552 (5.33)                  
  Low HDL-C (mmol/L)                                                                      
   No                       38 137 (93.74)   27 655 (92.92)   10 482 (95.96)   125.7493   \<0.0001
   Yes                      2547 (6.26)      2106 (7.08)      441 (4.04)                  
  Hyperglycaemia                                                                          
   No                       35 068 (86.20)   25 669 (86.25)   8323 (76.20)     0.2758     0.5994
   Yes                      5616 (13.80)     4092 (13.75)     2600 (23.80)                
  Hypertension                                                                            
   No                       32 216 (79.19)   23 863 (80.18)   8353 (76.47)     66.7443    \<0.0001
   Yes                      8468 (20.81)     5898 (19.82)     2570 (23.53.)               
  Hypertriglycerid a emia                                                                 
   No                       26 990 (66.34)   20 152 (67.71)   6838 (62.60)     93.4716    \<0.0001
   Yes                      13 694 (33.66)   9609 (32.29)     4085 (37.40)                
  MS                                                                                      
   No                       36 286 (89.19)   26 701 (89.72)   9585 (87.75)     32.08      \<0.0001
   Yes                      4398 (10.81)     3060 (10.28)     1338 (12.25)                
  BUN (mmol/L)                                                                            
   \<2.86                   5.44±1.54        637 (2.14)       248 (2.27)       33.0906    \<0.0001
   2.86--                   25 721 (86.43)   9202 (84.24)                                 
   7.14--                   3403 (11.43)     1473 (13.49)                                 
  Total                                                                                   
                            40 684(100)      29 761 (73.15)   10 923 (26.85)              

\*For drinking, 0=never drink, 1=drink occasionally, and 2=drink frequently; for smoking, 0=never smoke, 1=smoke occasionally and 2=smoke frequently. The figures in brackets are percentages.

BMI, body mass index; BUN, blood urea nitrogen; HDL-C, high-density lipoprotein cholesterol; MS, metabolic syndrome.

Relationship between components of MS and NSE {#s3b}
---------------------------------------------

Variables which had significant differences in the two NSE groups were adjusted. Based on multiple logistic regression analysis, elevated NSE level was found in MS individuals. In stepwise linear analysis of the relationship between MS components and NSE, a positive relationship was found in BMI (β=0.0627, p\<0.0001), TG (\<20 mmol/L, β=0.2553, p\<0.0001), SBP (75--200 mm Hg, β=0.0487, p\<0.0001), DBP (\<70 mm Hg, β=0.01846, p\<0.0001; ≥70 mm Hg, β=0.0156, p\<0.0001), HDL-C (0.75--1.25 mmol/L, β=8.4354, p\<0.0001) and FBG (6.00--20.0 mmol/L, β=0.041, p=0.0353). However, a negative relationship was found in FBG (\<6.00 mmol/L, β=−0.599, p\<0.0001). These results are shown in [table 2](#T2){ref-type="table"} and in [figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}.

![Multiple logistic regression analysis of the factors that influence neuron-specific enolase (NSE). Adjusted for sex, age, drink and blood urea nitrogen (BUN), the dependent variable was NSE, while the independent variable was metabolic syndrome (MS). The longitudinal coordinate represents potential factors that influence NSE, while the horizontal coordinate are ORs of NSE.](bmjopen-2017-020899f01){#F1}

![Stepwise correlation analysis of neuron-specific enolase (NSE) and metabolic syndrome (MS) components. The horizontal coordinate represents different components of MS; the longitudinal coordinate shows residual of NSE. Solid line: without adjustment; dotted line: adjustment for sex, age, drink and blood urea nitrogen. (A) Correlation of body mass index (BMI) with NSE. (B) Correlation of triglyceride (TG) with NSE. (C) Correlation of systolic blood pressure (SBP) with NSE. (D) Correlation of diastolic blood pressure (DBP) with NSE. (E) Correlation of high-density lipoprotein cholesterol (HDL-C) with NSE. (F) Correlation of fasting blood glucose (FBG) with NSE.](bmjopen-2017-020899f02){#F2}

###### 

Stepwise linear regression model of the relationship between metabolic syndrome (MS) components and neuron-specific enolase

  MS components              Unadjusted   Adjusted\*                                  
  ---------------- --------- ------------ ------------ ---------- -------- ---------- ----------
  BMI (kg/m^2^)    \<25      0.1057       0.0188       \<0.0001   0.0627   0.0098     \<0.0001
  ≥25              0.0077    0.0257       0.7639                                      
  TG (mmol/L)      \<20      0.3018       0.0224       \<0.0001   0.2553   0.0237     \<0.0001
  SBP (mm Hg)      75--200   0.0417       0.0017       \<0.0001   0.0487   0.0019     \<0.0001
  DBP (mm Hg)      \<80      0.0887       0.0083       \<0.0001   0.0294   0.6063     \<0.0001
  ≥80              0.0324    0.0062       \<0.0001     0.0734     0.0085   \<0.0001   
  HDL-C (mmol/L)   0.75--    7.5522       0.3982       \<0.0001   8.4354   0.4096     \<0.0001
  1.25--2.50       −0.2347   0.1393       0.0919       0.1196     0.1455   0.4111     
  FBG (mmol/L)     \<6.00    −0.5329      0.0704       \<0.0001   −0.599   0.074      \<0.0001
  6.00--20.00      0.1043    0.0388       0.0072       0.0937     0.0403   0.0202     

\*Adjusted for sex, age, drink and blood urea nitrogen.

β stands for coefficient. BMI, body mass index; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure; TG, triglyceride.

After adjusting potential risk factors, the relationship between NSE and MS changed as a function of NSE concentration. Results from stepwise regression analysis revealed that OR \<1 when NSE concentration ranges from 2.00 ng/mL to 7.50 ng/mL, indicating that NSE was negatively related to MS in this range. And OR \>1 when NSE concentration ranges from 7.50 ng/mL to 23.00 ng/mL, indicating that NSE was positively related to MS ([figures 3 and 4](#F3 F4){ref-type="fig"}).

![Stepwise logistic regression analysis between neuron-specific enolase (NSE) and metabolic syndrome (MS). Adjusted for sex, age and smoke. The longitudinal coordinate represents quartile segments of NSE; the horizontal coordinate is OR of MS.](bmjopen-2017-020899f03){#F3}

![Relationship between neuron-specific enolase (NSE) and metabolic syndrome (MS) and their 95% CIs (shade scope). The horizontal coordinate represents NSE; the longitudinal coordinate is lnOR. Solid line: without adjustment; dotted line: adjustment for sex, age, drink and blood urea nitrogen.](bmjopen-2017-020899f04){#F4}

Discussion {#s4}
==========

The findings of this research show differences in NSE concentration between MS and non-MS population. Moreover, there were correlations between MS components and NSE. The effect of MS on brain can be reflected by changes in the concentration of NSE. In the absence of serious lesion, NSE is retained in the nerve cell because there is no cellular damage. Thus, NSE would not be detectable in peripheral blood.[@R30] Therefore, NSE and MS components showed a certain association only in a limited range.

After adjusting a number of factors, there was weak correlation between BMI and NSE. In a previous study, Samanc *et al* reported that there was no correlation between BMI and NSE.[@R25] The difference between their findings and the findings in the present study might be partly ascribed to differences in sample size. In addition, the mean age of people enrolled in this study was 50.49±13.52 years, while in the study by Samanc *et al*, the mean ages of idiopathic intracranial hypertension and control groups were 35.40±9.85 and 37.10±9.65 years, respectively.

In this study, NSE was positively associated with risk of elevated TG. This is in agreement with the findings of Lindenstrom *et al* who reported that plasma TG was positively associated with ischaemic stroke.[@R31] Similar results were obtained by other workers.[@R32] However, there are some reports indicating no association between NSE and TGs at all.[@R34] Thus, from the viewpoint of previous research, the correlation between TG and stroke or ischaemic stroke was controversial, partly due to differences in blood samples used, some collected the non-fasting blood samples,[@R30] while others used fasting blood samples.[@R34] In the present research, TG levels were assessed on fasting blood samples, and serum NSE level was measured to evaluate brain injury. Elevated serum NSE has been shown to be related to the volume of brain infarction tissue.[@R36] Differences in the degrees of stroke impairment might be responsible for the disparities in the results from different studies. In addition, the criteria of abnormal TG used also varied. Therefore, more precise and rigorous investigations are required.

HDL-C showed a positive association with NSE at a range of 0.75--2.50 mmol/L, which indicated that HDL-C was positively associated with NSE in the normal range of HDL-C. Serum NSE levels could reflect impairment due to cerebral infarction.[@R20] This finding is inconsistent with the popular view that HDL-C level is a protective factor against stoke.[@R37] Indeed, it has been found that HDL-C is related to an increased risk factor of stroke in women.[@R38] However, in this study, the number of female participants was smaller than the number of males enrolled. This association between NSE and HDL-C has not been reported before. Several aspects of this phenomenon should be considered. Maybe in the other studies, emphasis was on the stoke events, while in the present study, NSE was used as a marker of brain damage (including stroke and other brain diseases). Some unknown mechanism may exist, which need to be discussed in the future. Another possible explanation could be that the relationship between cardiovascular disease and HDL-C affects the association between cerebrovascular diseases.[@R38]

Hypertension is associated with cerebrovascular diseases; patients who had hypertension were more susceptible to cerebrovascular diseases.[@R39] In this study, there was a positive correlation between SBP/DBP and NSE, when SBP ranges from 75 mm Hg to 200 mm Hg, and DBP \<70 mm Hg, which is in agreement with the results of González-Quevedo *et al* [@R27] had done. In addition, a study on the Atherosclerosis Risk in Communities found that high BP was the most important risk factor for all subtypes of stroke. It was explained that hypertension was associated with white matter lesions, which caused elevations in NSE levels.[@R27] However, the authors of the present study consider that hypertension might do harm to grey matter of the brain which is composed of a large number of neurons, and this damage might be reflected by changes in NSE.[@R44] Since image inspection was not performed in this study, further imaging examination is required to identify this damage. The underlying mechanism remains to be studied. In other subgroups of SBP and DBP, the correlation was not valid because of the lack of adequate population.

FBG had a negative association with NSE\<6.0 mmol/L. Low FBG leads to hypoglycaemia. Hypoglycaemia damages the brain because brain activity relies on the circulating glucose as its main energy source.[@R45] Thus, NSE decreased with increasing FBG (FBG\<6.0 mmol/L) in contrast to the positive association for FBG\>6.0 mmol/L. It is well known that elevated FBG is one of the risk factors for cerebrovascular diseases.[@R47] This is consistent with the results of the current study. The only difference was that different correlations were obtained for subgroups of FBG.

From the analyses results, there were links between NSE and each component of MS. [Figures 2](#F2){ref-type="fig"} and [4](#F4){ref-type="fig"} show that there might exist a connection between NSE and MS. When NSE concentration ranges from 2.00 ng/mL to 7.50 ng/mL, NSE levels showed negative correlation with MS. A positive correlation was found between NSE and MS when NSE concentration ranges from 7.50 ng/mL to 23.0 ng/mL. It might mean that that NSE has nutritional function in the brain at low concentrations. Thus, it can protect brain tissue at a certain concentration.[@R48] However, at a comparatively high level, NSE can reflect impairment of brain tissue.[@R15] Therefore, NSE concentration may be a potential predictor in the course of occurrences and development of MS. Cerebral vascular stenosis or infarction results in insufficient blood supply to the brain, leading to the functional injury of brain, and NSE can reflect the degree of brain injury.[@R49] The improvements in living standards have led to the rising incidence of MS. To some extent, the assay of NSE concentrations could predict a pathway for cardiovascular disease in MS populations. The advantage of the present study is that it is an epidemiological investigation based on a large sample size. This is essential for the validity and reliability of the results obtained.

Limitations {#s5}
===========

This is a cross-sectional study based on a large sample health check-up population, which varies from the general population. Thus, the representativeness of this conclusion is limited. In addition, the mechanism involved in the link between NSE and MS is still unclear. However, it is clear from this study that they probably have a causal relationship. In this study, NSE was not evaluated specifically for brain function. Moreover, MRI was not applied to evaluate the degree of impairment of brain due to financial constraints. This will be done in subsequent studies.
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